Single Gene Analysis tests in Dubai & UAE

Compare available Single Gene Analysis tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Analysis test prices

Showing 1–15 of 26 matching tests.

Single Gene Analysis diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5388 AMTN Gene Amelotin Deficiency Genetic Test This genetic test identifies pathogenic variants in the AMTN gene associated with amelogenesis imperfecta and related syndromes.	Whole Blood (EDTA/FTA Card) or Extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AMTN gene pathogenic variants", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of amelogenesis imperfecta", "Identification of genetic predisposition to related syndromes", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 82301-8 ICD-10: K00.5 Clinical summary This genetic test identifies pathogenic variants in the AMTN gene associated with amelogenesis imperfecta and related syndromes.
TEST-2937 ARX Gene-Associated Agenesis of Corpus Callosum with Abnormal Genitalia (XLAG) Genetic Test This diagnostic test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly with ambiguous genitalia (XLAG) syndrome and related neurological conditi...	Peripheral whole blood (3–5 mL venipuncture) or finger-prick blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARX gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Intragenic Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Continue all prescribed medications unless advised otherwise by your doctor"] Indications ["Individuals with clinical features suggestive of XLAG syndrome", "Family screening for ARX-related disorders", "Prenatal or preimplantation genetic diagnosis options"] Measurement technique Confirm with laboratory Codes LOINC: 80230-8 ICD-10: Q04.0 Clinical summary This diagnostic test evaluates the ARX gene for pathogenic variants associated with X-linked lissencephaly with ambiguous genitalia (XLAG) syndrome and related neurological conditions.
TEST-2884 CANT1 Gene Desbuquois Dysplasia Type 1 Genetic Test This test identifies pathogenic variants in the CANT1 gene associated with Desbuquois dysplasia type 1.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CANT1 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected Desbuquois dysplasia type 1", "Differential diagnosis of skeletal dysplasias"] Measurement technique Confirm with laboratory Codes LOINC: 94233-4 ICD-10: Q77.8 Clinical summary This test identifies pathogenic variants in the CANT1 gene associated with Desbuquois dysplasia type 1.
TEST-5982 CD320 Gene (Methylmalonic Aciduria, cblR Type) Genetic Test This genetic test analyzes the CD320 gene to detect mutations associated with methylmalonic aciduria, cblR type.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD320 gene sequence", "Pathogenic variants in CD320"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected methylmalonic aciduria, cblR type", "Carrier screening", "Family cascade testing"] Measurement technique Confirm with laboratory Codes LOINC: 81214-4 ICD-10: E71.120 Clinical summary This genetic test analyzes the CD320 gene to detect mutations associated with methylmalonic aciduria, cblR type.
TEST-4079 COQ2 Gene Coenzyme Q10 Deficiency Type 1 Genetic Test This genetic test identifies pathogenic variants in the COQ2 gene associated with primary coenzyme Q10 deficiency type 1.	Peripheral Whole Blood (3–5 mL venous blood or FTA card)	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COQ2 gene", "Copy number variations in the COQ2 gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected primary coenzyme Q10 deficiency type 1", "Family history of COQ2-related disorders", "Neurological symptoms suggestive of mitochondrial disease"] Measurement technique Confirm with laboratory Codes LOINC: 97943-6 ICD-10: E88.1 Clinical summary This genetic test identifies pathogenic variants in the COQ2 gene associated with primary coenzyme Q10 deficiency type 1.
TEST-4125 CRHR1 Gene Pulmonary Newborn Hypertension Genetic Test This test evaluates the CRHR1 gene for pathogenic variants associated with persistent pulmonary hypertension in newborns (PPHN).	Whole Blood or FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRHR1 gene variants", "Point mutations", "Indels", "Copy number variations"] Parameters [] Preparation [] Indications ["Diagnosis of PPHN", "Family planning evaluation", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: P29.3 Clinical summary This test evaluates the CRHR1 gene for pathogenic variants associated with persistent pulmonary hypertension in newborns (PPHN).
TEST-4640 CSTA Gene Peeling Skin Syndrome Type 4 Genetic Test This test identifies pathogenic variants in the CSTA gene associated with Peeling Skin Syndrome Type 4.	Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CSTA gene", "Point mutations", "Small indels", "Copy number variants"] Parameters [] Preparation [] Indications ["Suspected Peeling Skin Syndrome Type 4", "Diagnosis of rare autosomal recessive dermatosis"] Measurement technique Confirm with laboratory Codes LOINC: 55231-1 ICD-10: Q80.8 Clinical summary This test identifies pathogenic variants in the CSTA gene associated with Peeling Skin Syndrome Type 4.
TEST-5045 CYBB Gene (Chronic Granulomatous Disease, X‑Linked) Genetic Test This genetic test evaluates the CYBB gene for pathogenic variants associated with X-linked Chronic Granulomatous Disease (CGD).	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CYBB gene", "Copy number variations in the CYBB gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent whole blood transfusion (within 2 weeks)"] Indications ["Symptomatic males suspected of X-linked CGD", "Carrier screening for females", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-5 ICD-10: D71 Clinical summary This genetic test evaluates the CYBB gene for pathogenic variants associated with X-linked Chronic Granulomatous Disease (CGD).
TEST-2375 DVL1 Gene (Robinow Syndrome, Autosomal Dominant Type 2) Genetic Test This test detects pathogenic variants in the DVL1 gene associated with autosomal dominant Robinow syndrome type 2.	Peripheral Whole Blood (EDTA tube) or Capillary Blood on FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DVL1 gene"] Parameters [] Preparation ["Confirm a transfusion-free interval of at least 2 weeks before sample collection"] Indications ["Individuals with clinical features suggestive of Robinow syndrome", "Family members of individuals with a confirmed DVL1 pathogenic variant", "Couples with a family history of Robinow syndrome seeking reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.1 Clinical summary This test detects pathogenic variants in the DVL1 gene associated with autosomal dominant Robinow syndrome type 2.
TEST-4905 DYNC1H1 Gene Intellectual Disability, Autosomal Dominant 13 (MRD13) Genetic Test This genetic test identifies pathogenic variants in the DYNC1H1 gene, which are associated with autosomal dominant intellectual disability type 13 (MRD13).	Whole Blood (EDTA Tube) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DYNC1H1 gene"] Parameters [] Preparation ["No fasting or medication changes are needed"] Indications ["Unexplained global developmental delay", "Intellectual disability", "Specific brain malformations (e.g., pachygyria or polymicrogyria)", "Family history of autosomal dominant intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 94219-1 ICD-10: F78, Q04.8 Clinical summary This genetic test identifies pathogenic variants in the DYNC1H1 gene, which are associated with autosomal dominant intellectual disability type 13 (MRD13).
TEST-4479 ERCC4 Gene Xeroderma Pigmentosum Group F Genetic Test This test identifies pathogenic variants in the ERCC4 gene associated with Xeroderma Pigmentosum Group F.	Peripheral whole blood (EDTA) or FTA dried blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ERCC4 gene", "Deletions/Duplications in the ERCC4 gene"] Parameters [] Preparation ["A comprehensive clinical history and genetic counseling session with a detailed three-generation pedigree chart must be completed before specimen collection."] Indications ["Diagnostic confirmation of Xeroderma Pigmentosum Group F", "Carrier screening for individuals with a family history of XP-F", "Cancer surveillance guidance"] Measurement technique Confirm with laboratory Codes LOINC: 21613-5 ICD-10: Q82.1 Clinical summary This test identifies pathogenic variants in the ERCC4 gene associated with Xeroderma Pigmentosum Group F.
TEST-2689 KDM6A Gene Kabuki Syndrome Type 2 Genetic Test This test evaluates the KDM6A gene for pathogenic variants associated with Kabuki syndrome type 2.	Peripheral whole blood, isolated DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KDM6A gene sequence", "Copy Number Variations (CNVs) in KDM6A"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your treating physician.", "Inform the lab about all current medications."] Indications ["Suspected Kabuki syndrome type 2", "Confirmation of clinical diagnosis", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 94065-1 ICD-10: Q87.1 Clinical summary This test evaluates the KDM6A gene for pathogenic variants associated with Kabuki syndrome type 2.
TEST-3260 LARS2 Gene Hydrops, Lactic Acidosis, and Sideroblastic Anemia (HLASA) Genetic Test This test identifies pathogenic variants in the LARS2 gene, confirming the diagnosis of Hydrops, Lactic Acidosis, and Sideroblastic Anemia (HLASA) syndrome.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LARS2 gene", "Copy Number Variations (CNV) in the LARS2 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Informed consent required"] Indications ["Suspected HLASA syndrome", "Confirmation of diagnosis in symptomatic individuals", "Family planning and genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 94266-3 ICD-10: D64.0 Clinical summary This test identifies pathogenic variants in the LARS2 gene, confirming the diagnosis of Hydrops, Lactic Acidosis, and Sideroblastic Anemia (HLASA) syndrome.
TEST-4022 LPIN1 Gene Myoglobinuria Acute Recurrent Genetic Test This genetic test evaluates the LPIN1 gene for pathogenic variants associated with autosomal recessive recurrent myoglobinuria.	Whole blood, extracted DNA, or FTA card	21–28 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the LPIN1 gene", "Copy Number Variations (CNVs) in the LPIN1 gene"] Parameters [] Preparation ["Pre-test genetic counseling required", "Fasting status not specified"] Indications ["Suspected autosomal recessive recurrent myoglobinuria", "Family history of recurrent myoglobinuria", "Unexplained episodes of muscle breakdown and dark urine"] Measurement technique Confirm with laboratory Codes LOINC: 74807-9 ICD-10: M62.89 Clinical summary This genetic test evaluates the LPIN1 gene for pathogenic variants associated with autosomal recessive recurrent myoglobinuria.
TEST-4468 MMP14 Gene Winchester Syndrome Genetic Test This test identifies pathogenic variants in the MMP14 gene associated with Winchester syndrome.	Peripheral whole blood (EDTA), extracted genomic DNA, or dried blood spot (FTA card)	3–4 weeks standard; 2–week express option available	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MMP14 gene", "Copy number variants (CNVs) in the MMP14 gene"] Parameters [] Preparation ["No specific fasting required", "Inform collection team of latex, chlorhexidine, or alcohol-based antiseptic hypersensitivity"] Indications ["Suspected Winchester syndrome based on clinical presentation", "Family history of Winchester syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21619-0 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the MMP14 gene associated with Winchester syndrome.

Category overview

Single Gene Analysis: overview

Securing precise diagnostic confirmation for a suspected hereditary condition demands a deeply focused, high-resolution analytical approach to ensure absolute clarity. As a specialized offering within our Genetics department, Single Gene Analysis dives deeply into a targeted section of your DNA to identify intricate molecular changes associated with a known familial disease. By leveraging state-of-the-art diagnostic technology, this precise genomic screening delivers the definitive data needed to assess your risks, safely guiding personalized preventative care and specialized medical oversight. Highly regarded among premier diagnostic labs in Dubai and the UAE, DNA Labs guarantees strict patient confidentiality, uncompromising diagnostic accuracy, and prompt reporting for sensitive cases. Protect your long-term health—book your single gene analysis in UAE, coordinate a comfortable home sample collection, or connect with our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.